0QUD

MAINSTAY MEDICAL INTERNATIONAL PLC MAINSTAY MEDICAL INTERNATIONAL ORD SHS

TitleTime
Mainstay Medical Announces Results of Scheme Meeting and EGMFri 08/05/20 | 11:55
Statement re Publication and posting of Circular related to proposed ReorganizationWed 15/04/20 | 17:34
Mainstay Medical Announces Strategic Plans to Maximize Shareholder Value, Including Proposals to Establish New Holding Company and Delist Its Shares From Euronext Growth and Euronext ParisTue 07/04/20 | 15:23
Mainstay Medical Provides Company Update and Reports 2019 Full Year Financial ResultsTue 25/02/20 | 07:00
Holding(s) in CompanyWed 05/02/20 | 10:54
Total Voting RightsTue 04/02/20 | 15:20
Mainstay Medical Announces Completion of Day 100 Meeting with FDA Regarding Pre-Market Approval (PMA) Application for ReActiv8Wed 11/12/19 | 17:00
Mainstay Medical Announces Regulatory Approval from Australian Therapeutic Goods Administration (TGA) for ReActiv8Fri 06/12/19 | 07:00
Euronext Growth Dublin NoticeThu 31/10/19 | 08:00
Statement re Publication of Prospectus and AdmissionFri 25/10/19 | 16:00
Statement re Acceptance for filing by US FDA of Pre-Market Approval (PMA) Application for ReActiv8Tue 01/10/19 | 07:00
Holding(s) in CompanyTue 24/09/19 | 09:38
Holding(s) in CompanyFri 20/09/19 | 12:58
Holding(s) in CompanyFri 20/09/19 | 12:53
Result of AGMFri 20/09/19 | 11:01
Mainstay Medical Provides Company Update and Reports 2019 Half Year Financial ResultsFri 20/09/19 | 07:00
Notice of ResultsThu 12/09/19 | 16:00
Director/PDMR ShareholdingFri 16/08/19 | 16:31
Notice of AGMTue 13/08/19 | 07:00
Holding(s) in CompanyThu 01/08/19 | 14:44
Holding(s) in CompanyThu 01/08/19 | 09:00
Holding(s) in CompanyWed 31/07/19 | 15:29
Mainstay Medical International plc: Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with themTue 30/07/19 | 16:53
Mainstay Medical International plc: Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with themTue 30/07/19 | 16:45
Mainstay Medical Announces Completion of Financing TransactionsMon 29/07/19 | 16:33
Mainstay Medical Announces Completion of Pre-Submission Meeting with FDA Regarding Pre-Market Approval (PMA) Application for ReActiv8Wed 26/06/19 | 10:25
Statement re Mainstay Medical Provides Company Update and  Publishes 2018 Full Year ResultsThu 18/04/19 | 17:20
Mainstay Medical International plc: Total Voting RightsFri 01/03/19 | 07:00
Director/PDMR ShareholdingFri 01/02/19 | 14:40
Statement re Mainstay Medical to Showcase ReActiv8 and Key Clinical Data at the 13th German Spine Congress of the DWGMon 03/12/18 | 16:30
Block listing Interim ReviewMon 03/12/18 | 07:00
Mainstay Medical Announces Participation in 30th Annual Piper Jaffray Healthcare ConferenceWed 21/11/18 | 07:00
Mainstay Medical Announces Headline Results from ReActiv8-B Clinical StudyMon 19/11/18 | 07:00
Mainstay Medical International plc (?Mainstay Medical?): Notice of Change of Registered OfficeWed 31/10/18 | 07:00
Mainstay Medical Announces Board ChangeMon 24/09/18 | 07:00
Mainstay Medical International plc (?Mainstay? or the ?Company?) Result of AGMFri 21/09/18 | 10:56
Mainstay Medical Announces 2018 Half Year Financial Results and UpdateFri 21/09/18 | 07:00
Mainstay Medical Announces Date for 2018 Half Year ResultsTue 04/09/18 | 07:00
Mainstay Medical International plc (?Mainstay Medical? or the ?Company?) Notice of AGMWed 29/08/18 | 07:00
Statement re Appointment of Matthew Onaitis as Chief Financial OfficerMon 20/08/18 | 07:00
Statement re Completion of all implants in the ReActiv8-B StudyMon 09/07/18 | 07:00
Mainstay Medical Appoints Wolfgang Frisch as VP and Managing Director for GermanyWed 20/06/18 | 07:00
Block listing Interim ReviewFri 01/06/18 | 07:00
Mainstay Medical Announces CFO TransitionTue 22/05/18 | 07:00
Publication of a ProspectusFri 04/05/18 | 15:58
Update on Regulatory Application for ReActiv8 in AustraliaThu 05/04/18 | 07:00
Director/PDMR ShareholdingWed 28/03/18 | 12:11
Mainstay Medical International plc (?Mainstay? or the ?Company?): Total Voting RightsThu 01/03/18 | 07:00
Holding(s) in Company - ReplacementTue 20/02/18 | 17:31
Holding(s) in CompanyMon 19/02/18 | 17:38
Holding(s) in CompanyMon 19/02/18 | 17:34
Holding(s) in CompanyMon 19/02/18 | 17:33
Holding(s) in CompanyMon 19/02/18 | 17:28
Holding(s) in CompanyMon 19/02/18 | 17:24
Director/PDMR ShareholdingFri 16/02/18 | 15:13
Director/PDMR ShareholdingFri 16/02/18 | 15:06
Director/PDMR ShareholdingFri 16/02/18 | 14:30
Director/PDMR ShareholdingFri 16/02/18 | 14:29
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with themFri 16/02/18 | 14:08
Mainstay Medical Announces ?30 Million FinancingThu 15/02/18 | 07:15
Final ResultsThu 15/02/18 | 07:00
Statement re Mainstay confirms its continued eligibility to the PEA-PMETue 23/01/18 | 07:00
Mainstay Medical Announces Positive Outcome of Interim AnalysisMon 11/12/17 | 07:00
Block listing Interim ReviewFri 01/12/17 | 07:00
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with themTue 10/10/17 | 18:15
Mainstay Medical Announces Jason Hannon Joins Board of DirectorsMon 09/10/17 | 07:00
Result of AGMFri 22/09/17 | 14:45
Mainstay Medical Announces CEO Leadership TransitionTue 05/09/17 | 07:00
Mainstay Medical Announces Half Year Financial ResultsTue 05/09/17 | 07:00
Mainstay Medical Announces Date for 2017 Half Year ResultsMon 04/09/17 | 07:00
Notice of AGMWed 30/08/17 | 07:00
Mainstay Medical?s ReActiv8-B Clinical Trial Passes Mid-pointThu 03/08/17 | 07:00
Total Voting RightsTue 01/08/17 | 07:00
Total Voting RightsMon 03/07/17 | 07:00
Statement re Mainstay Medical to Host Key Opinion Leader Event on the Chronic Low Back Pain Treatment LandscapeThu 22/06/17 | 13:00
Mainstay Medical to Present at the JMP Securities 2017 Life Sciences ConferenceThu 15/06/17 | 07:00